MARKETABLE SECURITIES (Tables)

12 Months Ended

Jul. 31, 2021

Cash and Cash Equivalents [Abstract]

Schedule of Marketable Securities

As of July 31, 2021, and 2020, the Company’s marketable securities are presented below.

MARKETABLE SECURITIES

							Change in
							Fair Value
							For the
	Number						Year
	of		Fair Value at				Ended
	Shares		July 31, 2021		July 31, 2020		July 31, 2021
Common Shares of Entest Group, Inc. (ENTI)		66,667	$	340	$	260	$	80
Common Shares of Regen Biopharma, Inc. (RGBP)		29,076,665		393,989		5,814		388,175
Series A Preferred Shares of Regen Biopharma, Inc. (RGBPP)		2,907,666		139,422		4,362		135,060
Total			$	533,751	$	10,436	$	523,315